Loading clinical trials...
Loading clinical trials...
A Randomized, Open-label, Comparative Trial Comparing the Incidence of Hypophosphatemia in Relation to Treatment With Iron Isomaltoside/Ferric Derisomaltose and Ferric Carboxymaltose in Subjects With Iron Deficiency Anaemia (Phosphare-IDA-05)
Conditions
Interventions
Iron isomaltoside/ferric derisomaltose
Ferric carboxymaltose
Locations
15
United States
Pharmacosmos Investigational Site
Muscle Shoals, Alabama, United States
Pharmacosmos Investigational Site
Doral, Florida, United States
Pharmacosmos Investigational Site
Miami, Florida, United States
Pharmacosmos Investigational Site
Miami, Florida, United States
Pharmacosmos Investigational Site
Miami Lakes, Florida, United States
Pharmacosmos Investigational Site
Orlando, Florida, United States
Start Date
October 30, 2017
Primary Completion Date
May 29, 2018
Completion Date
May 29, 2018
Last Updated
February 25, 2020
NCT05251493
NCT05836961
NCT06642337
NCT06631612
NCT07394088
NCT06238895
Lead Sponsor
Pharmacosmos A/S
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions